Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations

Shmakova Anna^{1, 2, 3} , Lomov Nikolai^{1, 4} , Viushkov Vladimir⁴ , Tsfasman Tatyana¹ , Kozhevnikova Yana^{1, 5} , Sokolova Darina ^{6, 7, 8} , Pokrovsky Vadim ^{6, 7, 8} , Syrkina Marina⁴ , Germini Diego¹ , Rubtsov Mikhail^{4, 9} , Vassetzky Yegor^{1, 2}

Cancer Communications

John Wiley & Sons Inc.

1

Английский

154-158

Опубликовано

Внешняя ссылка

10.1002/CAC2.12370

43

2023

• ¹ UMR9018 Université Paris‐Saclay Centre national de la recherche scientifique, Gustave Roussy Villejuif 94805 France
• ² Koltzov Institute of Developmental Biology Russian Academy of Sciences Moscow 119334 Russia
• ³ Institute of Experimental Cardiology National Medical Research Centre of Cardiology Moscow 121552 Russia
• ⁴ Department of Molecular Biology Faculty of Biology Lomonosov Moscow State University Leninskie Gory Moscow 119991 Russia
• ⁵ Faculty of Medicine Lomonosov Moscow State University Moscow 119991 Russia
• ⁶ Laboratory of Combined Treatment Blokhin Cancer Research Center Moscow 115478 Russia
• ⁷ Department of Biochemistry Peoples’ Friendship University of Russia Moscow 117198 Russia
• ⁸ Center of Genetics and Life Sciences Sirius University of Science and Technology Federal Territory Sirius Sochi 354340 Russia
• ⁹ Department of Biochemistry Center for Industrial Technologies and Entrepreneurship Sechenov First Moscow State Medical University Moscow 119991 Russia